drugset / Trial / NCT00103298

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

NCT00103298 ↗

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as melphalan, leucovorin, oxaliplatin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving the drugs in different ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well isolated hepatic perfusion with melphalan followed by combination chemotherapy works in treating patients with unresectable liver metastases from colorectal cancer.

Timeline

Start
2004-12
Primary completion
—
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule — Intravenous
Subject Melphalan Small molecule — Other
Subject Oxaliplatin Small molecule — Intravenous
Subject fluorouracil Small molecule — Intravenous